NRx Pharmaceuticals, Inc. (NRXP) Discusses Regulatory Update and Development Pipeline Expansion for Preservative-Free Ketamine Formulation Transcript
2025-12-02 11:23:33 ET
NRx Pharmaceuticals, Inc. (NRXP) Discusses Regulatory Update and Development Pipeline Expansion for Preservative-Free Ketamine Formulation December 2, 2025 9:00 AM EST...
Read the full article on Seeking Alpha
For further details see:
NRx Pharmaceuticals, Inc. (NRXP) Discusses Regulatory Update and Development Pipeline Expansion for Preservative-Free Ketamine Formulation TranscriptNASDAQ: NRXPW
NRXPW Trading
3.32% G/L:
$0.028 Last:
76,526 Volume:
$0.027 Open:



